UTI Healthcare Fund Regular Plan-IDCW Payout
UTI Healthcare Fund Regular Plan-IDCW Payout: Mutual Fund Overview
UTI Healthcare Fund Regular Plan-IDCW Payout is an Sectoral-Pharma mutual fund with over 26.7 years of performance history. The scheme manages an AUM of ₹1106.71 Cr and has a NAV of ₹218.6405. It is rated '4' stars by analysts. Investors can begin a SIP with as little as ₹500.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 10.37%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 10.37% at 12 Mar 2026 06:50 PM
Fund Details
NAV 218.6405
Sub-Type Sectoral-Pharma
Rating 4
Min. SIP Amount ₹500.0
Fund Age(Year) 26.7
Fund Size(in Crores) 1106.71
Fund Performance
1 Month -0.31%
3 Month -1.16%
6 Month -4.38%
1 Year 10.37%
3 Year 25.79%
5 Year 15.28%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.21%) Market Cap Mid Cap 29.98 Large Cap 27.77 Small Cap 40.45 Top Sectors Healthcare 97.37 Services 0.84 Top Holding Divi's Laboratories 3.52 Ipca Laboratories 2.17 Laxmi Dental 0.26 Dr. Reddy's Laboratories 3.48 Acutaas Chemicals 1.07 Dr. Lal Pathlabs 1.26 Emcure Pharmaceuticals 0.94 Ajanta Pharma 7.04 Krishna Institute 1.55 Alkem Laboratories 3.47 Anthem Biosciences 1.91 Biocon 0.7 Orchid Pharma 0.56 Cipla 1.83 Alembic Pharmaceuticals 0.52 Metropolis Healthcare 1.66 Syngene International 0.69 Aurobindo Pharma 2.66 Glenmark Pharmaceuticals 4.25 Jupiter Life Line Hospitals 2.06 Procter & Gamble Health 2.21 Sanofi Consumer Healthcare India 0.98 Jubilant Pharmova 0.7 Apollo Hospitals Enterprise 3.75 Windlas Biotech 1.13 Sai Life Sciences 2.07 Pfizer 1.77 Sudeep Pharma 2.19 Fortis Healthcare 2.98 Global Health 2.02 Max Healthcare Institute 2.85 Sun Pharmaceutical Industries 9.42 Lupin 5.79 Rainbow Children's 0.85 Caplin Point Laboratories 2.23 Viyash Scientific 2.11 Aarti Pharmalabs 0.84 Eris Lifesciences 1.84 Vijaya Diagnostic Centre 1.09 Gland Pharma 3.54 Cohance Lifesciences 2.66 Marksans Pharma 1.65 Aster DM Healthcare 1.94
Debt & Others (1.8%) Sector Allocation CBLO 0.01 Net Current Assets 1.79 Debt Credit Ratings Debt Category Others 1.79
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.27%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Kamal Gada
Education Mr. Gada is B.com, CA, CS, & CFA
Experience Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 20
Date of Incorporation 1999-06-28
Total AUM 396376.12
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
